Provided by Tiger Fintech (Singapore) Pte. Ltd.

IceCure Medical Ltd.

1.02
+0.03013.04%
Post-market: 1.01-0.0100-0.98%19:01 EDT
Volume:1.02M
Turnover:961.93K
Market Cap:59.79M
PE:-3.57
High:1.02
Open:0.8800
Low:0.8100
Close:0.9899
Loading ...

IceCure Medical Ltd. Announces $10 Million Rights Offering to Fund Cryoablation Technology Expansion

Reuters
·
Yesterday

Icecure Announces Record Date for Rights Offering for up to $10 Million

THOMSON REUTERS
·
Yesterday

IceCure Medical Ltd. Announces U.S. Patent Allowance for Innovative Cryogen Flow Control Technology

Reuters
·
09 Jun

Icecure Medical Price Target Maintained With a $2.50/Share by HC Wainwright & Co.

Dow Jones
·
30 May

Buy Rating for Icecure Medical: Anticipated FDA Approval and Strategic Partnerships Drive Positive Outlook

TIPRANKS
·
29 May

IceCure Medical Reports Q1 2025 Financial Results

TIPRANKS
·
29 May

IceCure Q1 2025 Earnings Call Summary and Q&A Highlights: FDA Engagement and Geographic Expansion

Earnings Call
·
28 May

IceCure (ICCM) Q1 2025 Earnings Call Transcript

Motley Fool Transcribing
·
28 May

IceCure Medical Reports Q1 2025 Revenue Decline by 2% with Gross Margin Decrease to 30%

Reuters
·
28 May

Icecure Medical Q1 2025 EPS $(0.06) Beats $(0.08) Estimate, Sales $725.00K Miss $750.00K Estimate

Benzinga
·
28 May

Icecure Medical Reports First Quarter 2025 Financial Results

THOMSON REUTERS
·
28 May

Press Release: IceCure Medical Reports First Quarter 2025 Financial Results

Dow Jones
·
28 May

Icecure Medical Ltd expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
26 May

IceCure Medical Secures $2 Million Bridge Loan from Epoch

TIPRANKS
·
21 May

IceCure Medical Ltd. to Release First Quarter 2025 Financial Results

Reuters
·
21 May

IceCure Medical’s Shareholders Approve Key Agenda Items at Special Meeting

TIPRANKS
·
16 May

IceCure Medical Advances Toward FDA Approval for ProSense® in Breast Cancer Treatment

TIPRANKS
·
30 Apr

IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-Stage Breast Cancer

PR Newswire
·
30 Apr

IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium

PR Newswire
·
28 Apr

Icecure Medical’s Growth Potential Highlighted by Clinical Progress and Strategic Financial Position

TIPRANKS
·
29 Mar